Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 08    symbols : BXRX    save search
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K twitter stocktwits trandingview |
Health Technology
 | | O: 4.15% H: 22.51% C: 15.95%
bx1000 trial
Gainers vs Losers
73% 27%

Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M twitter stocktwits trandingview |

AGBA | $2.5 100.0% 56.6% 200M twitter stocktwits trandingview |
Finance
MLEC | $2.47 76.43% 42.62% 78M twitter stocktwits trandingview |
n/a
NUWE | $0.334 29.96% 40.99% 2.5M twitter stocktwits trandingview |
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.86 46.25% 32.8% 180K twitter stocktwits trandingview |

VIVK | $1.43 33.65% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M twitter stocktwits trandingview |

SDIG A | $3.64 35.32% 26.0% 990K twitter stocktwits trandingview |

PROK | $2.72 33.33% 24.58% 2.6M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.